BrightPath Biotherapeutics Co., Ltd.TSE 4594

ブライトパス・バイオ株式会社 · Pharmaceutical · FY ends Mar

Share price at FY-end
—
FY ending Mar 2026
Market cap at FY-end
—
Dividend per share
—
Avg. director pay
¥17.5M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 楽天証券株式会社共有口 3,441,200 2.47% — —
2 株式会社SBI証券 3,423,094 2.46% — —
3 Ueda Yagi Tanshi Co., Ltd.
Asset-management company of Makoto Ueda
2,800,000 2.01% — —
4 BNYM SA/NV FOR BNYM FOR BNY GCM CLIENT ACCOUNTS M LSCB RD 1,857,304 1.33% — —
5 日本証券金融株式会社 1,457,400 1.04% — —
6 松井証券株式会社 1,449,900 1.04% — —
7 マネックス証券株式会社 1,143,971 0.82% — —
8 妹尾 浩弥 1,000,000 0.71% — —
9 三菱UFJeスマート証券株式会社 796,000 0.57% — —
10 GMOクリック証券株式会社 664,000 0.47% — —

Officers' holdings and pay

NameTitleSharesValuePay
永井 健一 President & Representative Director 240,000 — —
山田 亮 Director 185,000 — —
Hirotaka Takeuchi Director — — —
岸野 努 Audit & Supervisory Board Member — — —
阿部 武敏 Audit & Supervisory Board Member — — —
山口 芳泰 Audit & Supervisory Board Member — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Mar 2026 — ¥-11.70 — — 138,891,300
FY ending Mar 2025 — ¥-14.12 — — 90,491,300
Source: annual securities reports on EDINET. Values are estimates. Methodology